Vectura Group PLC (LON:VEC) insider Andrew Derodra acquired 127 shares of the stock in a transaction that occurred on Wednesday, January 17th. The stock was purchased at an average price of GBX 118 ($1.60) per share, for a total transaction of £149.86 ($203.23).

Andrew Derodra also recently made the following trade(s):

  • On Friday, December 8th, Andrew Derodra acquired 153 shares of Vectura Group stock. The stock was purchased at an average price of GBX 98 ($1.33) per share, for a total transaction of £149.94 ($203.34).
  • On Wednesday, November 8th, Andrew Derodra acquired 156 shares of Vectura Group stock. The stock was purchased at an average price of GBX 96 ($1.30) per share, for a total transaction of £149.76 ($203.09).

Vectura Group PLC (LON:VEC) opened at GBX 111.80 ($1.52) on Friday. Vectura Group PLC has a twelve month low of GBX 86.50 ($1.17) and a twelve month high of GBX 166.97 ($2.26).

VEC has been the topic of several research analyst reports. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Vectura Group in a report on Thursday, November 16th. Numis Securities lowered their price objective on Vectura Group from GBX 205 ($2.78) to GBX 170 ($2.31) and set a “buy” rating on the stock in a report on Thursday, November 9th. Royal Bank of Canada upgraded Vectura Group to a “sector performer” rating and set a GBX 119 ($1.61) price objective on the stock in a report on Thursday, December 14th. Shore Capital reiterated a “buy” rating on shares of Vectura Group in a report on Thursday, November 9th. Finally, Peel Hunt reiterated a “hold” rating and issued a GBX 160 ($2.17) price objective on shares of Vectura Group in a report on Wednesday, November 15th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Vectura Group has a consensus rating of “Buy” and a consensus target price of GBX 174 ($2.36).

TRADEMARK VIOLATION WARNING: “Andrew Derodra Acquires 127 Shares of Vectura Group PLC (VEC) Stock” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2018/01/20/andrew-derodra-acquires-127-shares-of-vectura-group-plc-vec-stock.html.

About Vectura Group

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.

Insider Buying and Selling by Quarter for Vectura Group (LON:VEC)

Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.